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EDITORIAL	SUMMARY:			
Directing	assembly	of	extra-embryonic	trophoblast	stem	cells	with	embryonic	stem	cells	to	
recapitulate	post-implantation	mouse	embryogenesis.	
SUMMARY	
Mammalian	embryogenesis	requires	the	coordination	of	embryonic	and	extra-embryonic	tissues	to	
enable	implantation	into	the	uterus	and	post-implantation	development	to	establish	the	body	plan.	
Mouse	embryonic	stem	cells	(ESCs)	are	a	useful	tool	for	studying	pluripotent	embryonic	tissue	in	vitro.	
However,	 they	cannot	undertake	correct	embryogenesis	alone.	Many	attempts	 to	model	 the	early	
embryo	in	vitro	involve	the	aggregation	of	ESCs	into	spheroids	of	variable	size	and	cell	number	that	
undertake	 germ-layer	 specification	 but	 fail	 to	 recapitulate	 the	 characteristic	 architecture	 and	
arrangement	of	tissues	of	the	early	embryo.	Here,	we	describe	a	protocol	to	generate	the	first	embryo-
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like	structures	by	directing	the	assembly	of	mouse	ESCs	and	extra-embryonic	trophoblast	stem	cells	
(TSCs)	in	a	3D	extracellular	matrix	(ECM)	into	structures	we	call	‘polarized	embryo-like	structures’.	By	
establishing	the	medium	and	culture	conditions	needed	to	support	the	growth	of	both	stem	cell	types	
simultaneously,	embryonic	architecture	 is	generated	within	4	d	of	co-culture.	This	protocol	can	be	
performed	by	those	proficient	in	standard	ESC	culture	techniques	and	can	be	used	in	developmental	
studies	 to	 investigate	 the	 interactions	 between	 embryonic	 and	 extra-embryonic	 tissues	 during	
mammalian	development.	
		
INTRODUCTION		
At	implantation,	the	mouse	embryo,	known	as	a	blastocyst,	is	made	up	of	three	distinct	tissues,	which	
are	arranged	in	a	specific	configuration	to	develop	into	a	structure	known	as	the	egg	cylinder.	One	of	
these	 tissues	 is	 the	 pluripotent	 embryonic	 epiblast,	 which	 gives	 rise	 to	 the	 fetus	 and	 forms	 a	
cupshaped	 epithelium	 at	 the	 distal	 side	 of	 the	 conceptus.	 Abutting	 the	 epiblast	 is	 one	 of	 two	
extraembryonic	 tissues,	 the	 extra-embryonic	 ectoderm	 (ExE),	 which	 is	 derived	 from	 the	
trophectoderm	and	positioned	at	the	proximal	side	of	the	embryo,	giving	rise	to	the	fetal	portion	of	
the	placenta.	The	third	tissue,	the	visceral	endoderm	(VE),	gives	rise	to	the	yolk	sac	of	the	embryo.	
This	 forms	 a	 monolayer	 of	 cells	 that	 envelops	 the	 other	 two	 tissue	 compartments.	 These	 extra-
embryonic	 tissues	 not	 only	 nourish	 the	 embryo	 as	 it	 grows,	 they	 also	 provide	 essential	 signals	 to	
pattern	the	epiblast,	ensuring	that	the	body	plan	is	established	correctly.	In	this	protocol,	we	describe	
a	system	to	model	the	early	development	of	the	mouse	embryo	ex	vivo	that	utilizes	cells	derived	from	
both	embryonic	and	extra-embryonic	tissues	to	mimic	in	vivo	embryogenesis.	
Modelling	embryogenesis	with	ESCs	alone	
Mouse	embryonic	stem	cells	(ESCs)	can	be	derived	from	the	pre-implantation	blastocyst	and	
are	 transcriptionally	 equivalent	 to	 the	 epiblast	 of	 the	mouse	 embryo	 just	 before	 implantation,	 at	
embryonic	day	4.5	(E4.5)1.	These	cells	are	a	useful	tool	to	investigate	the	early	development	of	the	
pluripotent	embryonic	tissue	in	the	first	few	days	of	embryogenesis	in	vitro.		However,	when	allowed	
to	 differentiate	 in	 2D	 adherent	 culture,	 these	 cells	 cannot	 undertake	 embryogenesis	 without	 the	
support	of	the	 in	vivo	environment.	Instead,	they	differentiate	into	neural	tissue2	or	can	be	coaxed	
into	 generating	 other	 lineages	 by	 the	 administration	 of	 growth	 factors	 to	 bias	 cell	 fate3,4.	 When	
cultured	 in	 3D	 with	 extracellular	 matrix	 (ECM),	 mammalian	 ESCs	 and	 their	 reprogrammed	
counterparts,	induced	pluripotent	stem	cells	have	been	shown	to	develop	with	time	into	organ-like	
structures	including	fully	organised	retina	and	brain-like	tissue5–9.	The	generation	of	these	structures,	
termed	 ‘organoids’,	 occurs	 through	 self-assembly/self-organisation	 of	 cells	 from	 an	 initially	
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homogenous	 pluripotent	 population.	 Whilst	 some	 organoid	 structures	 exhibit	 endogenous	 axial	
patterning6,10,	ESCs	in	culture	fail	to	reproducibly	establish	body	axes	without	exogenous	signals	and	
do	not	generate	a	structure	resembling	whole-embryonic	architecture.		Initial	attempts	to	model	early	
post-implantation	mouse	embryogenesis	focussed	on	the	use	of	ESCs	alone	to	generate	3D	aggregates	
of	 hundreds	 of	 cells.	 This	 technique	 leads	 to	 the	 formation	 of	 ‘embryoid	 bodies’	 that	 can	
spontaneously	induce	domains	of	polarised	gene	expression11.	Some	of	these	structures	have	been	
termed	 ‘gastruloids’	 as	 they	 sometimes	 initiate	 the	 regionalised	expression	of	 germ	 layer	markers	
associated	with	the	onset	of	gastrulation	during	embryogenesis12,13.	However,	these	structures	do	not	
develop	as	embryos	and,	consequently,	do	not	recapitulate	the	specific	architecture	of	the	embryo	at	
post-implantation	 stages,	 nor	 do	 they	 represent	 the	 extra-embryonic	 lineages	 present	 in	 the	
mammalian	embryo.		
	
When	embedded	in	ECM	and	when	starting	from	individual	cells,	ESCs	more	faithfully	mimic	
embryonic	 architecture.	 They	 develop	 to	make	 a	 ‘rosette-like’	 structure	 similar	 to	 the	 embryonic	
epiblast	at	the	time	of	implantation14.	Just	as	in	the	embryo,	β1-integrin	signalling	mediated	by	laminin	
in	the	ECM	leads	to	cell	polarisation,	which	in	turn	underpins	the	formation	of	the	ESC	‘rosette’.	At	the	
centre	 of	 the	 rosette,	 a	 lumen	 opens	 analogous	 to	 the	 opening	 of	 the	 pro-amniotic	 cavity	 during	
embryogenesis14.		
Development	of	the	protocol	
Given	that	the	embryo	at	early	stages	comprises	extra-embryonic	tissues	in	addition	to	the	
embryonic	epiblast,	the	extra-embryonic	ectoderm	(ExE)	and	the	visceral	endoderm	(VE)	and	these	
have	been	demonstrated	to	be	important	for	establishing	the	body	plan15,	we	introduced	trophoblast	
stem	cells	(TSCs)	derived	from	the	ExE	of	the	embryo16	into	co-culture	with	ESCs	embedded	in	ECM17.	
We	also	developed	a	medium	to	support	the	culture	of	ESCs	and	TSCs	simultaneously,	and	used	ECM	
as	a	substitute	for	the	basement	membrane	secreted	by	the	VE,	which	we	showed	previously	to	be	
critical	for	epiblast	polarisation	and	lumenogenesis	in	vivo14.	
We	demonstrated	that	ESCs	and	TSCs	in	this	system	could	self-assemble	into	structures	that	
mimicked	 embryo	 architecture	 within	 4	 days	 of	 culture17.	 These	 structures	 underwent	 similar	
morphogenesis	to	give	rise	to	a	cavity	akin	to	the	pro-amniotic	cavity	in	the	mouse	egg	cylinder,	which	
is	shared	between	the	embryonic	and	extra-embryonic	tissues.	Despite	the	fact	that	only	22%	of	all	
structures	formed	comprised	both	ESCs	and	TSCs;	when	these	2	types	of	stem	cell	met,	more	than	
90%	 of	 the	 structures	 developed	 a	 characteristic	 embryo-like	 morphology	 demonstrating	 the	
robustness	of	 	 this	model	 system17.	Here	we	provide	a	 step-by-step	protocol	 for	 generating	 these	
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’polarised	embryo-like	structures’,	also	called	‘ETS-embryos’	(ESCs	and	TSCs	in	culture),	using	custom	
developed	media,	 ECM	 and	 optical	 plastic	 for	 high-resolution	 imaging	 of	 structures.	 This	method	
demonstrates	a	new	tool	that	can	be	used	to	investigate	early	mouse	embryogenesis	using	a	tractable	
stem	cell	model.	
Potential	applications	of	polarised	embryo-like	structures	and	comparison	to	other	methods		
We	 showed	 that	 our	 polarised	 embryo-like	 structures	 (ETS-embryos)	 recapitulate	 pro-
amniotic	cavity	formation	in	the	mouse	embryo	and	therefore	can	be	used	to	study	how	this	cavity	
develops	(Fig.	1g-h).	They	also	recapitulate	cell	fate	decisions	and	axial	patterning	events	associated	
with	early	post-implantation	development17.	We	showed	that	they	can	develop	an	area	of	regionalised	
mesoderm	at	the	boundary	between	ESC	and	TSC	compartments,	which	is	analogous	to	the	domain	
which	marks	the	onset	of	gastrulation	at	the	proximo-posterior	side	of	the	epiblast18.	Opposite	this	
region	of	mesoderm,	cells	acquire	a	more	anterior-like	fate,	upregulating	genes	normally	expressed	in	
the	anterior	epiblast	of	the	E6.5	embryo,	such	as	Pou3f1,	Oct4,	Slc7a3	and	Utf1	17,19,20.	This	indicates	
changes	 in	 the	 transcriptional	 program	 that	 reflects	 a	 gradient	 of	 cell	 fates	 across	 the	 embryonic	
compartment.	Further	development	of	these	polarised	embryo-like	structures	leads	to	specification	
of	a	small	number	of	Primordial	Germ	Cell	(PGC)-like	cells.	 	Amazingly,	these	PGC-like	cells	become	
specified	in	the	correct	spatial	location,		at	the	boundary	between	ESC	and	TSC	compartments,	within	
the	T/Brachyury-positive	domain	17.	We	showed	that	this	PGC-like	cell	specification	occurs	via	BMP	
signalling,	as	it	does	in	the	embryo,	and	both	induction	of	PGC	and	mesoderm	markers	in		are	preceded	
by	the	 localised	 induction	of	Wnt21,22.	Thus,	polarised	embryo-like	structures	mimic	the	spatial	and	
temporal	events	of	early	mouse	embryogenesis17.		
In	addition	to	being	a	useful	tool	to	study	cavitation	in	the	embryo,	because	polarised	embryo-
like	structures	can	break	symmetry	and	specify	mesoderm	in	a	regionalised	manner,	these	structures	
can	be	used	to	study	how	mesoderm	becomes	specified.	In	comparison	to	embryoid	bodies	and	the	
gastruloids	derived	from	them,	ETS-embryos	stand	out,	in	that	both	whole	embryo	architecture	and	
germ	layer	specification	occur	as	a	result	of	the	activity	of	endogenous	signals	provided	by	the	TSC-
derived	 extra-embryonic	 compartment.	 This	 is	 in	 contrast	 to	 coaxing	 ESCs	 in	 3D	 aggregates	 to	
differentiate	by	supplementing	the	culture	medium	with	growth	factors	such	as	recombinant	Wnt	or	
BMP11–13.	In	this	respect,		ETS	embryos	are	useful	for	the	study	of	how	embryonic-and	extra-embryonic	
tissues	interact	in	the	embryo	to	specify	embryo	architecture	and	the	future	body	axes.	Furthermore,	
the	identity	and	role	of	endogenous	signals	in	the	these	embryo-like	structures	may	be	deduced	by	
adding	 inhibitors	 of	 known	 morphogens	 to	 the	 culture	 system,	 and	 monitoring	 the	 effects	 on	
mesoderm	specification.	
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Embryoid	bodies	and	gastruloids	which	are	derived	from	them	comprise	only	one	cell	type.	As	
such,	 they	may	be	useful	 in	 the	 study	of	 how	ESCs	differentiate	 in	 response	 to	 the	delivery	of	 an	
exogenous	signal.	Moreover,	although	polarised	embryo-like	structures	lack	a	VE	layer,	which	is	critical	
for	natural	embryo	development,	the	fact	that	they	are	more	simple	than	the	real	embryo	but	still	
comprise	embryonic	and	extra-embryonic	 tissues	aids	 investigation	of	 the	 interaction	between	the	
epiblast	 and	 the	 ExE.	 This	 is	 because	 the	 absence	 of	 the	 VE	means	 it	 cannot	 confound	 results	 by	
producing	its	own	signals	which	affect	embryogenesis.	
	
In	addition	to	being	a	valuable	tool	to	investigate	the	patterning	of	the	body	axes,	ETS	embryos	
also	have	 several	other	potential	uses	 in	developmental	 studies.	 This	 in	 vitro	model	of	 the	mouse	
embryo	can	complement	work	 in	vivo	as	the	amenability	of	ESCs	and	TSCs	to	genetic	manipulation	
means	that	they	can	be	used	to	generate	embryo-like	structures	that	are	knockout	for	a	particular	
gene	 of	 interest.	 This	 may	 be	 an	 efficient	 way	 to	 reveal	 novel	 functions	 of	 genes	 in	 early	
embryogenesis,	and	to	perform	molecular	studies,	without	producing	knockout	animals	which	is	both	
expensive	 and	 laborious.	 This	 approach	 may	 also	 aid	 in	 the	 identification	 and	 study	 of	 ‘hidden’	
developmental	phenotypes	that	might	be	masked	in	the	mouse	as	maternally	produced	protein	can	
compensate	when	the	zygotic	genome	is	compromised.	Furthermore,	the	tissue-specific	role	of	a	gene	
can	be	easily	probed	in	this	system	by	knocking	it	out	in	either	the	embryonic	or	extra-embryonic	cell	
line	only.	Whilst	tissue-specific	knockouts	of	mice	may	require	the	generation	of	a	construct	including	
a	tissue	specific	promoter,	this	can	be	avoided	using	this	embryo-like	model	as	constitutive	promoter	
systems	can	be	introduced	into	each	cell	line	independently.		
	
Current	limitations	of	the	protocol	and	potential	future	directions	
By	mixing	ESCs	and	TSCs	in	suspension	and	allowing	3D	structures	to	grow,	the	ETS	embryo	
culture	is	heterogeneous.	On	average,	22%	of	all	structures	in	a	single	well	are	comprised	of	both	stem	
cell	types,	whereas	the	majority	of	other	structures	comprise	only	ESCs	and	TSCs17.	Despite	this,	by	
plating	 the	 recommended	 cell	 numbers,	 a	 yield	 of	 >100	 polarised	 embryo-like	 structures	 can	 be	
achieved	from	a	single	experiment	in	a	single	8-well	µ-plate	(Ibidi).	This	is	more	than	one	can	analyse	
per	day.	We	have	not	tried	to	optimise	this	method	to	generate	embryo-like	structures	that	would	
develop	beyond	early	post-implantation	stages.	This	may	require	culturing	conditions	allowing	more	
efficient	exchange	of	gas	and	nutrients	to	permit	the	growth	of	larger,	more	complex	structures	akin	
to	embryos	at	later	developmental	stages.	As	polarised	embryo-like	structures	are	structurally	robust	
enough	to	survive	manual	removal	from	the	Matrigel	after	4	days	in	culture,	they	could	be	maintained	
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in	 suspension	 using	 a	 rotary	 orbital	 shaker,	 or	 rotation	 culture	 using	 a	 spinning	 bioreactor23.	
Alternatively,	a	perfusion	bioreactor	could	support	structures	remaining	embedded	in	ECM.	
	In	addition,	the	protocol	in	its	current	form	yields	embryo-like	structures	without	a	layer	to	
represent	the	VE,	which	is	the	precursor	to	the	yolk-sac.	One	improvement	would	be	to	establish	a	
protocol	to	include	extra-embryonic	stem	cells	derived	from	the	primitive	endoderm	(‘XEN’	cells)	into	
co-culture.	To	do	this,	the	medium	composition	described	here	may	need	to	be	altered	to	support	the	
growth	 and	 proliferation	 of	 all	 three	 cell	 types.	 Furthermore,	 it	 has	 been	 shown	 that	 XEN	 cells	 in	
conventional	culture	are	more	equivalent	to	the	primitive	endoderm	of	the	pre-implantation	mouse	
embryo	24,25	 	but	cells	which	are	equivalent	to	the	post-implantation	VE	lineage	might	be	required.	
Several	studies	have	shown	that	XEN	cells	can	be	coaxed	to	become	more	VE-like	when	treated	with	
BMP	26,27,	and	so	it	may	be	that	XEN	cells	would	require	‘priming’	towards	a	VE-like	state	in	this	way	
before	they		can	be	used	to	generate	VE	tissue	in	our	embryo-like	structures.	The	use	of	Matrigel	in	
the	current	protocol	partially	compensates	for	the	VE,	as	this	tissue	is	known	to	secrete	the	basement	
membrane	 essential	 for	 epiblast	 polarisation	 and	 lumenogenesis14.	 If	 VE-like	 cells	 were	 to	 be	
incorporated	into	our	embryo-like	structures,	it	is	likely	that	these	cells	will	secrete	ECM	components,	
thus	providing	the	culture	with	exogenous	sources	of	ECM.		
Experimental	design		
Medium	optimisation.	 	Our	 approach	 is	 based	on	 that	developed	by	Bedzhov	&	Zernicka-
Goetz14	 in	which	epiblast	architecture	 is	mimicked	using	ESCs	 in	ECM	by	 introducing	TSCs	 into	 the	
system.	To	develop	a	medium	that	would	support	both	types	of	stem	cells	 in	these	conditions,	we	
began	by	mixing	25%	Neurobasal	A,	25%	DMEM/F-12	 (Gibco	Life-Technologies)	and	50%	MegaCell	
RPMI	medium	(Sigma)	(vol/vol).	We	found	that	medium	based	on	one	of	these	components	alone	was	
not	sufficient	to	support	the	growth	of	both	cell	types	simultaneously	in	culture,	and	that	the	basal	
composition	that	would	support	ESC	and	TSC	growth	at	the	same	time	required	RPMI	medium,	which	
is	usually	used	for	conventional	TSC	culture,	to	be	mixed	with	Neurobasal-A	and	DMEM-F/12	media,	
which	is	used	to	make	N2B27	for	conventional	ESC	culture.	If	one	or	several	of	these	basal	components	
were	missing,	one	or	both	cell	types	failed	to	grow	and/or	began	to	differentiate.		
The	medium	we	developed	also	included	extra-nutrients	to	promote	cell	growth	and	survival	
in	culture,	including	L-glutamine	and	sodium	pyruvate	(Gibco	Life-Technologies).	We	supplemented	
this	medium	with	FGF4	and	heparin,	to	promote	TSC	self-renewal	in	vitro,	but	excluded	the	inhibitors	
PD0325901,	 CHIR99021,	 and	 Leukaemia	 Inhibitory	 Factor	 (LIF),	 which	 maintain	 ground	 state	
pluripotency	in	ESCs28.	This	was	because	we	wanted	ESCs	to	be	able	to	differentiate	in	co-culture.	This	
medium	 also	 included	 10%	 (vol/vol)	 FBS.	 Serum	 contains	 undefined	 factors	 which	 promote	 cell	
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proliferation	and	differentiation,	and	is	required	for	mouse	blastocysts	to	develop	into	egg	cylinders	
in	vitro29,30.	We	hypothesised	that	serum	would	provide	essential	signalling	components	to	ESCs	and	
TSCs	 in	co-culture	that	might	promote	self-assembly	of	embryo-like	structures,	but	we	kept	serum	
content	low	to	minimise	the	possibility	of	precocious	differentiation.	If	higher	concentrations	of	serum	
were	added	to	the	culture,	such	as	20%	or	30%,	ETS-embryo	morphology	was	compromised	and	the	
structures	failed	to	develop	a	cavity	at	their	centre.		
By	 keeping	 the	 serum	 concentration	 low	 in	 the	 medium,	 we	 found	 that	 this	 medium	
composition	 supported	 the	proliferation	and	 formation	of	 rosette-like	 structures	of	both	ESCs	and	
TSCs	in	Matrigel,	which	later	self-assembled	into	3D	structures	that	resembled	the	egg	cylinder	(Fig.	
1).	These	structures	more	faithfully	mimicked	the	structure	of	the	embryo	than	embryoid	bodies	and	
had	similar	cell	number	and	tissue	volume	to	the	mouse	egg	cylinder17.			
	
Cells.		The	use	of	different	cell	lines	does	not	affect	the	efficiency	of	ETS	embryo	generation.		
We	have	routinely	used	transgenic	reporter	ESCs	in	the	co-culture	system	to	report	different	aspects	
of	 ETS-embryo	 development	 including	mesoderm	 specification31,	 PGC-like	 cell	 specification32	 or	 to	
demarcate	the	ESC	compartment	by	possession	of	fluorescent	membranes33	(STEP	1).	Cells	can	also	
be	derived	de	novo	 from	a	 transgenic	mouse	 line-of-interest	 and	used	 in	 this	protocol.	Additional	
information	on	the	derivation	and	culture	techniques	of	stem	cells	from	the	mouse	embryo	can	be	
found	in:	‘Manipulating	the	Mouse	Embryo:	a	Laboratory	Manual’34.	Notably,	ESCs	and	TSCs	can	still	
form	embryo-like	structures	even	when	derived	from	different	mouse	strains.	
ECM	support.		We	recommend	the	use	of	Growth	Factor	Reduced	Matrigel	Matrix,	(STEP	13)	
however	every	batch	of	matrix	must	be	 individually	tested	 in	the	system	to	ensure	reproducibility.	
Matrigel	lots	and	batches	can	be	tested	before	ETS-embryo	generation	by	embedding	ESCs	and	TSCs	
separately	 and	 culturing	 for	 72h	 to	 ensure	 the	 cells	 grow	 as	 expected	 (STEPS	 14-15).	 For	 ESCs	
embedded	in	Matrigel,	a	single	lumen	should	develop	at	the	centre	of	the	structure	within	48h14	and	
the	 cells	 should	 express	 the	 epiblast	 markers	 Sox2	 or	 Otx2.	 TSCs	 embedded	 in	 Matrigel	 should	
continue	to	express	ExE	markers	such	as	Eomes	or	Tfap2C	as	described	below	(Fig.2).		
Imaging.		ETS-embryos	can	be	fixed,	stained	and	imaged	in	situ	at	any	time-point	after	plating,	
(STEPS	16-22)	but	mesodermal	lineages	appear	only	after	4-5	days	in	culture	(Fig.2)	(see	ANTICIPATED	
RESULTS).	If	live-imaging	is	required,	we	recommend	plating	all	structures	in	a	single	plane	using	the	
‘3D	 on	 top’	 method	 (see	 BOX	 1).	 The	 ‘3D	 on	 top’	 method	 can	 be	 used	 with	 various	 dish	 sizes,	
depending	on	the	requirements	of	the	experiment.	Plating	volumes	for	example	dishes	(Mattek	Glass	
Bottomed	culture	dishes	and	Ibidi	angiogenesis	µ-plates)	are	included	in	Supplementary	Table	1.		
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MATERIALS	
REAGENTS	
• Mitotically	 inactivated	 mouse	 embryonic	 fibroblasts	 (MEFs)	 ready	 to	 use	 (R&D	 systems,	
PSC001)	or	prepared	from	mouse	embryos	as	described	in	Box	1.	
• Mouse	trophoblast	stem	cells	(derived	as	described	in	Box	2).	
• Mouse	ESCs	derived	from	the	mouse	embryo	at	blastocyst	stages	(as	described	in	Box	3)	or	
obtained	commercially	from	suppliers	such	as	The	Jackson	Laboratory.	
• DMEM/F-12	(Gibco-	Life	Technologies,	Cat	No	21331-020)	
• DMEM	(+	L-glutamine)	(Gibco-	Life	Technologies	Cat.	No.	41966052)	
• Neurobasal	A	liquid	(Gibco-	Life	Technologies	Cat.	No.	10888-022)	
• MegaCell	RPMI-1640	medium	(Sigma	Aldrich	Cat.	No.	M3817)	
• N2	supplement	(Made	as	described	in	RSU)	
CRITICAL:	 Home-made	 N2	 supplement	 yields	 better	 resuts	 than	 commercial	 N2	 (Thermo	 Fisher	
Scientific	Cat.	No.	17502048).	The	use	of	some	brands	of	commercial	N2	can	result	in	ETS-embryos	
with	smaller	or	no	cavities.	Before	using	commercial	N2	in	this	protocol,	batch	test	the	commercial	
product	by	using	it	to	make	N2B27	medium	(described	in	‘Reagent	setup’)	and	use	this	to	culture	ESCs	
embedded	in	Matrigel.	ESC	cysts	should	make	lumens	within	48h.		
• Commercial	ETS-embryo	Medium	(Cell	Guidance	Systems	Cat.	No.	M13-25)	
• Human	Apo-tansferrin,	cell	culture	tested	(Sigma	Aldrich	Cat.	No.	T1147-100MG)	
• Bovine	Albumin	Fraction	V	(7.5%	solution,	(wt/vol))	(Gibco-	Life	Technologies	Cat.	No.	15260-
037)	
• Chemically	defined	Human	insulin	solution	(Sigma	Cat.	No.	I9278-5ML)	
• Putrescine	dihydrochloride	powder,	cell	culture	tested	(Sigma	Aldrich	Cat.	No.	P5780-5G)	
• Sodium	selenite	powder,	cell	culture	tested	(Sigma	Aldrich	Cat.	No.	S5261-10G)	
• Progesterone	powder,	cell	culture	tested	(Sigma	Aldrich	Cat.	No.	P8783-1G)	
• B27	supplement	minus	AO	(Gibco-	Life	Technologies	Cat.	No.	10889-038)	
• Embryonic	 stem	 cell	 grade	 foetal	 bovine	 serum	 (FBS)	 (Gibco-	 Life	 Technologies	 Cat.	 No.	
10439024)		
CRITICAL:	FBS	must	be	tested	in	ESC	culture	before	use	in	the	ETS	embryo	system.	To	do	this,	
make	up	FC2iLIF	medium	(described	in	‘Reagent	setup’)	and	culture	ESCs	in	adherent	culture	
on	gelatin	in	this	medium	for	two	weeks.	Assess	ESC	growth	and	proliferation	during	this	time,	
colony	 morphology,	 and	 expression	 of	 pluripotency	 markers.	 If	 the	 FBS	 is	 of	 appropriate	
quality,	 then	ESCs	 should	become	confluent	within	48h	of	 culture,	 and	 colonies	 should	be	
rounded	 and	 raised,	 with	 tightly	 packed	 cells.	 Expression	 of	 pluripotency	markers	 can	 be	
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tested	 by	 immunofluorescence	 staining	 to	 detect	 expression	 of	 Oct4,	 Nanog,	 and	 Sox2	
transcription	factors,	which	should	be	localised	to	the	nucleus.	To	check	for	differentiation,	
cells	can	also	be	immunostained	for	T/Brachyury	protein,	which	should	not	be	expressed	in	
naïve	 pluripotent	 ESCs.	 The	 gold	 standard	 test	 for	 naïve	 pluripotent	 ESCs	 is	 to	 perform	 a	
chimera	 assay	 in	 which	 ESCs	 are	 introduced	 into	 the	 pre-implantation	 embryo	 and	 their	
contribution	is	checked.	This	is	recommended	for	cell-lines	which	have	been	derived	but	not	
previously	validated	in	this	way.		
• L-glutamine	 (Gibco-	 Life	 Technologies	 Cat.	 No.	 25030-024)	 or	 Glutamax	 (Gibco-	 Life	
Technologies	Cat.	No.	35050-038)	
• 2-Mercaptoethanol	(2	ME)	solution	(50	mM)	(Gibco-	Life	Technologies	Cat.	No.	31350-010)	
CAUTION:	2-Mercaptoethanol	is	toxic.	Use	personal	protective	equipment	and	discard	waste	
appropriately.	
• MEM	Non-Essential	Amino	Acid	Solution	(NEAA)	(Gibco-	Life	Technologies	Cat.	No.	11140035)	
• Sodium	pyruvate	100mM	solution	(Gibco-Life	Technologies	Cat.	No.	11360039)	
• Penicillin-streptomycin	solution	(Gibco-Life	Technologies	Cat.	No.	15140122)	
• PD0325901	(Stemgent,	04-0006)	
• CHIR99021	(Stemgent,	Cat.	No.	04-0004)		
• Recombinant	mouse	Leukaemia	Inhibitory	Factor	(LIF)	(Stemfactor,	Cat.	No.	03-0011)	
• Recombinant	Human	Fibroblast	Growth	Factor	4	(FGF-4)	(Peprotech	Cat.	No.	100-31)	
• Heparin	(Sigma	Cat.	No.	H3149)	
• Sterile	Phosphate	Buffered	Saline	(PBS)	(Gibco-Life	Technologies	Cat.	No.	10010056)	
• Trypsin-EDTA	(Gibco-Life	Technologies	Cat.	No.	25300054)	
• Growth	Factor	Reduced	Matrigel	matrix	(BD,	Corning	Cat.	No.	356234)	
• Autoclaved	water		
• Ethanol	solution	(Sigma	Aldrich	Cat.	No.	02860-4x25ml)	
• Gelatin	from	cold	water	fish	skin	(Sigma	Aldrich	Cat.	No.	G7765)	
• Bovine	serum	albumin	(BSA)	(Sigma	Aldrich	Cat.	No.	A3311-50G)	
• Triton-X-100	(Sigma	Aldrich	Cat.	No.	T9284-100ML)	
• 16%	Paraformaldehyde	(Electron	Microscopy	Sciences,	Cat.	No.	15710)	
CAUTION:	Paraformaldehyde	is	toxic.	Use	personal	protective	equipment	and	discard	waste	
appropriately.	
• Antibodies	specific	to	Tfap2C	(1:200;	Santa	Cruz,	Cat.	No.	sc-8977),	Brachyury/T	(1:400;	R&D	
systems,	Cat.	No.AF2085),	anti-GFP	(1:1000;	Nacalai	Biochemicals,	cat.	No.	04404-84)	Eomes	
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(1:400;	Abcam,	Cat.	No.	ab183991),	Sox2	(1:200;	Santa	Crux,	Cat.	No.	sc-365823),	Otx2	(1:200;	
R&D	systems,	Cat.	No.	AF1979).	
• Fluorophore	conjugated	secondary	antibodies	(1:500):	donkey	anti-goat	Alexa	Fluor	488	(Life	
Technologies,	 Thermofisher	 Scientific	 A11055),	 donkey	 anti-goat	 Alexa	 Fluor	 568	 (Life	
Technologies,	 Thermofisher	 Scientific	 A21447),	 donkey	 anti-rat	 Alexa	 Fluor	 488	 (Life	
Technologies,	 Thermofisher	 Scientific	 A21208),	 donkey	 anti-mouse	 Alexa	 Fluor	 568	 (Life	
Technologies,	 Thermofisher	 Scientific	 A10037),	 donkey	 anti-rabbit	 Alexa	 Fluor	 647	 (Life	
Technologies,	Thermofisher	Scientific	A31573).	
	
EQUIPMENT	
• ibiTreat	µ-plates,	8-well	(Ibidi,	Cat.	No.	80826)	
• Angiogenesis	μ-plate	(Ibidi,	Cat.	No.	IB-81506)	
• Glass-bottomed	–culture	dish	(MatTek,	Cat.	No.	P35G-1.5-14-C)	
• Nunclon	 Tissue	 culture	 plates,	 six	well,	 12	well	 (Thermofisher	 Scientific	 Cat	No.	 140675	&	
150628)	
• Sterile	Syringe	Filters	CA	0.2µm,	33mm	(Gilson	cat.	No.	ALG422A)	
• Nikon	inverted	microscope	for	tissue	culture		
• Set	of	laboratory	pipettes	for	tissue	culture	work	
• P1000,	P200,	P20,	P10,	P2	filter	pipette	tips	
• CO2	incubator	(New	Brunswick,	Galaxy	170R)	set	at	5%	CO2	and	37°C.	
• 	Biological	safety	cabinet	(Nuaire	Cell	Gard	Class	II)	
• Vacuum	pump	(Integra	Vacusafe)	
• Ice	and	ice	bucket	
• Sterile	1.5	ml	Eppendorf	safelock	tubes	(Fisher	Scientific	Cat.	No.	0030120086)	
• Sterile	15ml	falcon	tubes	(Corning	430791)	
	
REAGENT	SETUP	
CRITICAL:	All	tissue	culture	reagents	must	be	kept	sterile	and	prepared	in	a	Biological	safety	cabinet	
suitable	for	tissue	culture	(see	EQUIPMENT).		
FBS	
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Heat-inactivate	 the	 FBS	 by	 incubation	 for	 30	 minutes	 in	 a	 water	 bath	 at	 56°C.	 Filter-aliquot	 the	
inactivated	serum	using	sterile	syringe	filters	(0.2µm,	33mm)	and	store	in	40ml	volumes	at	-20°C	for	
up	to	six	months.	
Apo-transferrin	solution	
To	prepare	a	stock	apo-transferrin	solution,	dissolve	100mg	of	powder	in	10ml	of	sterile	autoclaved	
water.	Spin	the	solution	at	1100g	for	3	minutes	at	room	temperature,	then	transfer	to	a	fresh	sterile	
1.5	ml	Eppendorf	tube.	Filter-aliquot	into	1ml	volumes	and	store	at	-20°C	for	up	to	eight	weeks.	
Progesterone	
To	prepare	a	stock	progesterone	solution,	dissolve	0.006g	of	powder	in	10ml	of	Ethanol.	Filter-aliquot	
this	 solution	 into	 sterile	 1.5	ml	 Eppendorf	 tubes	 and	 cover	 lids	 of	 tubes	with	 parafilm	 to	 prevent	
evaporation.	Store	at	-20°C	for	up	to	six	months.	
Sodium	selenite	
To	prepare	a	stock	sodium	selenite	solution,	dissolve	0.006g	of	powder	in	10ml	of	sterile	autoclaved	
water.	Filter-aliquot	this	solution	into	sterile	1.5	ml	Eppendorf	tubes	and	store	at	-20°C	for	up	to	six	
months.	
Putrescine	dihydrochloride	
To	 prepare	 a	 stock	 putrescine	 dihydrochloride	 solution,	 dissolve	 0.8g	 of	 powder	 in	 5ml	 of	 sterile	
autoclaved	water.	Filter-aliquot	this	solution	into	sterile	1.5	ml	Eppendorf	tubes	and	store	at	-20°C	for	
up	to	six	months.	
FGF-4	solution	reconstitution	
Reconstitute	 the	 lipophilized	 FGF-4	 according	 to	 the	manufacturer’s	 instructions.	 Prepare	 a	 1000x	
(25ug/ml)	stock	solution	by	dilution	using	PBS	0.1%	BSA	(wt/vol).	Aliquot	into	sterile	1.5	ml	Eppendorf	
tubes	and	store	at	-80°C	for	up	to	eight	weeks.	Do	not	re-freeze	after	thawing.	
Heparin	solution	reconstitution	
Prepare	a	1000x	(1mg/ml)	stock	solution	(wt/vol)	of	heparin	solution	by	dissolving	10mg	heparin	in	
10ml	of	PBS.	Aliquot	into	sterile	1.5ml	Eppendorf	tubes	and	store	at	-80°C	for	up	to	six	months.	Do	not	
re-freeze	after	thawing.	
Gelatin	solution	
To	prepare	a	0.1%	gelatin	solution	(wt/vol)	dissolve	1g	of	gelatin	in	100ml	of	water	and	autoclave	the	
solution.	Store	at	4°C	for	1	month.	
Feeder	Cell	‘FC’	Medium	
Prepare	a	solution	comprising	the	following:	DMEM	supplemented	with	15%	FBS	(vol/vol),	2mM	L-
glutamine,	 0.1mM	 2-ME,	 0.1mM	 NEAA,	 1mM	 sodium	 pyruvate,	 and	 1%	 penicillin-streptomycin	
(vol/vol).	Store	at	4°C	and	use	within	1	month.	
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FC	2iLIF	Medium	
Supplement	 the	 FC	medium	 solution	with	 PD0325901	 (1µM),	 CHIR99021	 (3µM)	 and	 LIF	 (0.1mM).	
Store	at	4°C	and	use	within	1	week.	
N2	supplement	
Prepare	 a	 solution	 comprising	 the	 following:	 DMEM/F-12	 supplemented	 with	 10%	 human	 apo-
transferrin	solution	(vol/vol),	10%	Bovine	Albumin	Fraction	V	(vol/vol),	25%	human	insulin	solution,	
putrescine	dihydrochloride	(1611	μg/ml),	sodium	selenite	(0.6	μg/ml)	and	progesterone	(0.6	μg/ml).	
Filter-aliquot	this	solution	into	sterile	0.5	ml	Eppendorf	tubes	and	store	at	-20°C	for	up	to	1	month.	
Avoid	repeated	freeze-thaw	cycles.	
N2B27	
Prepare	 a	 solution	 comprising	 the	 following:	 50%	 DMEM/F-12	 (vol/vol)	 and	 50%	 Neurobasal	 A	
(vol/vol),	 supplemented	 with	 2mM	 L-glutamine,	 0.1mM	 2ME,	 0.5x	 N2	 supplement,	 1x	 B27	
supplement.	Store	at	4°C	and	use	within	2	weeks.	
N2B27	2iLIF	
Supplement	the	N2B27	solution	with	PD0325901	(1µM),	CHIR99021	(3µM)	and	LIF	(0.1mM).	Store	at	
4°C	and	use	within	1	week.	
ETS-embryo	medium	
Prepare	a	solution	comprising	the	following:	40%	‘MegaCell’	RPMI	(vol/vol),	25%	DMEM/F-12	(vol/vol)	
and	25%	Neurobasal	A	(vol/vol)	supplemented	with	10%	FBS	(vol/vol),	2mM	L-glutamine,	0.1mM	2ME,	
0.5mM	sodium	pyruvate,	0.25x	N2	supplement	(made	in	house),	0.5x	B27	supplement,	plus	12.5	ng/ml	
FGF4	and	500ng/ml	heparin.	Also	add	1%	penicillin-streptomycin	(vol/vol).	Store	at	4°C	and	use	within	
1	week.	Alternatively,	the	complete	formulation	can	be	purchased	as	a	ready-to-use	formula	from	Cell	
Guidance	Systems,	(Cat.	No:	M13-25)	
TS	cell	medium	
Prepare	 a	 solution	 comprising	 the	 following:	 ‘MegaCell’	 RPMI	 with	 20%	 FBS	 (vol/vol),	 2mM	 L-
glutamine,	0.1mM	2-ME,	1mM	sodium	pyruvate,	and	1%	penicillin-streptomycin	(vol/vol).	Store	at	4°C	
and	use	within	1	month.	
TSF4H	medium	
Supplement	the	TS	cell	medium	solution	with	25ng/ml	of	recombinant	FGF4	and	500ng/ml	of	heparin.	
Store	at	4°C	and	use	within	1	week.		
4%	PFA	solution	
Dilute	the	16%	PFA	solution	four	times	in	PBS	to	produce	4%	PFA	(vol/vol).	Store	at	4°C	and	use	within	
1	week.	
Blocking	buffer	for	antibody	incubations	
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Prepare	a	solution	of	PBS	with	3%	BSA	(wt/vol).	Store	at	4°C	and	use	within	1	week.	
	
Box	1:		Preparation	of	mitotically	inactivated	mouse	embryonic	fibroblasts	(MEFs)	
A	brief	procedure	follows,	more	detailed	instructions	can	be	be	found	in	Nagy	et	al.35.			
Additional	materials	required:	
CBA/C57Bl6	(F1)	mice			
CAUTION:	 Experiments	 using	 mice	 must	 conform	 to	 Institutional	 and	 National	 regulations.	 We	
obtained	 approval	 to	 use	 the	 procedure	 below	 from	 Animals	 (Scientific	 Procedures)	 Act	 1986	
Amendment	Regulations	2012	following	ethical	review	by	the	University	of	Cambridge	Animal	Welfare	
and	Ethical	Review	Body	(AWERB).	
Mitomycin-C	(Sigma-Aldrich	Cat.	No.	M4287)	
DNaseI	(New	England	Biolabs	Cat.	No.	M0303S)	
Procedure:	
i) Mate	 CBA/C57Bl6	 (F1)	 mice	 and	 sacrifice	 pregnant	 females	 after	 13	 or	 14	 days	 post	
coitum.		
CRITICAL:	Carry	out	all	dissection	steps	in	a	tissue	culture	hood	under	aseptic	conditions	
using	sterile	instruments.	
ii) Dissect	out	uterine	horns	in	sterile	PBS,	and	remove	embryos	using	fine	forceps.		
iii) Dissect	away	the	brain	and	red	organs	from	each	embryo,	then	mince	the	tissue	using	a	
razor	blade	until	it	can	be	pipetted.	
iv) Digest	the	minced	tissue	using	0.05%	trypsin-EDTA	and	100ul	of	DNaseI	per	embryo,	and	
incubate	for	15	minutes	at	37°C.			
v) Inactivate	the	trypsin	using	freshly	prepared	FC	medium,	and	transfer	the	cell-suspension	
to	a	falcon	tube.		
vi) Centrifuge	at	300g	for	5	min,	then	subsequently	remove	the	supernatant	and	resuspend	
the	cells	in	fresh	FC	medium.	
vii) Plate	the	cells	on	gelatine	coated	tissue	culture	dishes	and	culture	overnight	at	5%	CO2	
and	37°C.	
viii) Change	the	medium	the	following	day	to	remove	dead	and	unattached	cells.		
ix) Expand	the	cells	until	confluent,	and	then	inactivate	using	Mitomycin-C	at	10µg/ml	
suspended	in	PBS.		
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PAUSEPOINT:	Once	inactivated,	MEFs	can	be	kept	in	the	incubator	for	up	to	2	weeks	until	
needed,	if	medium	is	changed	regularly.	
	
END	BOX	1	
Box	2:		Derivation	of	Trophoblast	stem	cells	(TSCs)	
Trophoblast	 stem	 cells	 can	 be	 derived	 from	 the	 mouse	 embryo	 at	 blastocyst	 or	 early	 post-
implantation	stages.	Steps	for	derivation	from	pre-implantation	blastocysts	are	outlined	below,	but	
more	detailed	protocols	are	also	available36.	
Additional	materials	required	
Mice	of	 the	desired	 strain.	 	We	have	used	CBA	x	C57Bl/6	 (F1	mice)	 and	 transgenic	mice	of	mixed	
genetic	background.	Please	note	that	ESCs	and	TSCs	do	not	need	to	be	derived	from	the	same	mouse	
strain	 to	 form	 ETS-embryos.	 Experiments	 using	 mice	 must	 conform	 to	 Institutional	 and	 National	
regulations.		We	obtained	approval	for	these	experiments	from	The	Animals	(Scientific	Procedures)	
Act	 1986	 Amendment	 Regulations	 2012	 following	 ethical	 review	 by	 the	 University	 of	 Cambridge	
Animal	Welfare	and	Ethical	Review	Body	(AWERB).	
M2	medium	(Sigma,	M7167)	
Procedure:	
i) Before	starting,	prepare	‘conditioned	medium’	by	culturing	MEFs	in	TS	medium	for	3	days.	
Collect	the	medium	and	store	for	use	during	derivation.	
ii) Plate	MEFs	on	4-well	tissue	culture	plates	at	a	density	of	4x104	cells	per	well	and	culture	
in	TS	cell	medium	overnight	at	5%	CO2	and	37°C.	
iii) Mate	 mice	 and	 sacrifice	 pregnant	 females	 after	 4.5	 days	 post	 coitum	 to	 obtain	 pre-
implantation	blastocysts.		
iv) Dissect	out	the	uterus,	flush	uterine	horns	using	M2	medium,	and	collect	the	blastocyst	
stage	embryos.	
v) Replace	the	TS	cell	medium	on	the	MEFs	with	TSF4H	medium	and	seed	one	blastocyst	per	
well	in	the	four-well	plates	covered	with	MEFs.		
vi) Culture	overnight	at	5%	CO2	and	37°C,	and	allow	blastocysts	to	attach	to	the	MEFs	and	
form	outgrowths.	
vii) Replace	the	medium	each	day.	
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viii) Once	 the	 outgrowths	 have	 expanded,	 aspirate	 the	medium	 and	 wash	 with	 PBS,	 then	
dissociate	the	outgrowths	using	0.05%	trypsin-EDTA.	Incubate	for	10	minutes	at	5%	CO2	
and	37°C.	
ix) Inactivate	 the	 trypsin	 using	 70%	 conditioned	 medium,	 plus	 1.5x	 TSF4H	 (TS	 medium	
containing	 37.5	 ng/ml	 FGF4	 and	 1.5	 µg/ml	 heparin)	 medium	 then	 disaggregate	 the	
outgrowths	by	pipetting	up	and	down.	
x) Incubate	at	5%	CO2	and	37°C,	and	change	the	medium	every	other	day	until	TSC	colonies	
begin	to	appear.	The	number	of	days	for	cells	to	appear	will	vary	(usually	from	6-10	days),	
but	epithelial	colonies	with	clear	boundaries	should	form.	Cells	other	than	TSCs	may	also	
appear,	in	which	case,	pick	the	colonies	of	TSCs	using	a	pipette	and	re-plate	in	new	four	
well-plates	coated	with	MEFs	and	culture	at	5%	CO2	and	37°C	in	TSF4H	medium.	
xi) Continue	to	expand	the	TSCs.	On	average,	cells	need	to	be	passaged	every	3-4	days,	or	
when	wells	are	80%	confluent.	Cultures	should	be	split	at	a	ratio	of	1:10.		To	passage	TSCs:	
incubate	with	0.05%	trypsin-	EDTA	for	3-5	minutes;	neutralise	with	an	equal	volume	of	
TSC	 medium;	 gently	 disaggregate	 cells	 with	 a	 pipette;	 spin	 down	 cells	 (1000g	 for	 3	
minutes);	resuspend	in	TSC		medium;	and	plate	on	a	fresh	plate	of	mitotically	inactivated	
MEFs.	16		
xii) TSCs	can	be	cultured	longer	term	on	MEFs	or	can	be	cultured	in	MEF-free	conditions	on	
gelatin-coated	 tissue	 culture	 plates	 by	 keeping	 the	 cells	 in	 MEF-conditioned	 TS	 cell	
medium	 (more	 details	 can	 be	 found	 in	 Tanaka,	 200636	 or	 Rossant,	 200637)	 As	 a	 third	
alternative,	 TS	 cells	 can	 also	 be	maintained	 in	 completely	 defined	 conditions	 detailed	
protocols	to	maintain	TSCs	in	this	way	have	been	developed	by	Kubaczka	et	al,	201438	and	
by	Ohinata	et	al,	201439.	TSCs	maintained	in	all	conditions	are	suitable	for	generating	ETS-
embryos.	
PAUSEPOINT	TSCs	can	be	frozen	for	storage	by	freezing	at	-80°C	in	TS	freezing	medium	
(10%	DMSO,	70%	TS	cell	medium,	20%	FBS)	
END	BOX	2	
Box	3:		Derivation	of	ESCs	
This	is	briefly	described	below.		More	detailed	protocols	for	how	to	derive	ESCs	from	mouse	embryos	
are	available	should	further	guidance	be	required	34.	
Additional	materials	required:	
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Female	Mice	of	the	desired	strain.		To	date,	we	have	used	129	ESCs,	E14	ESCs,	and	have	derived	ESCs	
from	transgenic	mice	of	a	mixed	genetic	background.	All	these	strains	are	suitable	to	generate	ETS-
embryos.	 Experiments	 using	 mice	 must	 conform	 to	 Institutional	 and	 National	 regulations.	 We	
obtained	 approval	 for	 these	 experiments	 from	 the	 Animals	 (Scientific	 Procedures)	 Act	 1986	
Amendment	Regulations	2012	following	ethical	review	by	the	University	of	Cambridge	Animal	Welfare	
and	Ethical	Review	Body	(AWERB).	
Procedure:	
i) Recover	blastocysts	from	pregnant	female	mice	and	seed	on	inactivated	MEF	feeder	cells	
in	FC2iLIF	medium.		
ii) Culture	overnight	at	5%	CO2	and	37°C.	
iii) Allow	 the	blastocysts	 to	hatch,	attach	 to	 the	MEFs	and	 form	outgrowths.	 	 This	usually	
takes	48	hours.	
iv) Once	 the	 outgrowths	 have	 expanded,	 dissociate	 these	 by	 washing	 with	 PBS	 and	
incubating	with	0.05%	Trypsin-EDTA	for	10	minutes.		
v) Inactivate	 the	 trypsin	with	 fresh	 FC2iLIF	medium	 and	 disaggregate	 the	 outgrowths	 by	
pipetting	up	and	down.		
vi) Culture	at	5%	CO2	and	37°C,	changing	the	medium	every	other	day.	ESC	colonies	should	
appear	within	1	week	of	culture.			
PAUSEPOINT:	ESCs	can	be	frozen	for	storage	by	freezing	at	-80°C	in	FC	freezing	medium	
(10%	DMSO,	70%	FC	medium,	20%	FBS)	
END	BOX	3	
PROCEDURE	
Cell	culture	TIMING-	minimum	of	1	week	
CAUTION:	 The	 cell	 lines	 used	 in	 your	 research	 should	 be	 regularly	 checked	 to	 ensure	 they	 are	
authentic	and	are	not	infected	with	mycoplasma.	
1) Establish	both	TSC	and	ESC	cultures	by	carrying	out	options	A	and	B.		Manage	ESC	and	TSC	
culture	and	passaging	so	that	passaging-days	become	synchronised.	MEF	Feeder	cells	need	
not	be	removed	to	begin	the	ETS-embryo	experiment.	Feeder-free	conditions	are	preferable	
for	ESC	culture,	but	MEFs	will	not	contaminate	the	culture	if	they	are	still	present	when	you	
start	the	experiment.	When	ESCs	and	TSCs	are	confluent	(80%)	on	the	same	day,	proceed	to	
the	next	step	to	generate	ETS	embryos.		
A) TSC	culture	
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i. Plate	mitotically	inactivated	mouse	embryonic	fibroblasts	(MEFs)	in	a	six-well	tissue	culture	
plate	at	half	the	density	normally	used	for	ESC	culture	(1	×	105	cells/ml).	Culture	in	FC	medium	
at	5%	CO2	and	37°C	for	at	least	24	hours,	to	allow	the	MEFs	to	attach	to	the	plate.	
ii. Thaw	a	vial	of	frozen	TSCs	as	quickly	as	possible	and	re-suspend	in	TSF4H	medium	for	culture.	
Remove	the	FC	medium	from	the	MEF	plate	and	seed	the	TSC	suspension	on	top	of	the	MEFs	
(Typically,	~1-3×	105	TSCs	can	be	plated	per	well	of	a	six-well	plate).		
iii. Culture	overnight	at	5%	CO2	and	37°C	to	allow	the	TSCs	to	attach,	then	replace	the	medium	
with	fresh	TSF4H	medium.		
?	TROUBLESHOOTING	
iv. Continue	to	culture	the	cells,	changing	the	culture	medium	every	two	days.		Passage	the	cells	
as	described	 in	Box	2.	CRITICAL	STEP	TSCs	can	be	passaged	up	to	~20	times	 for	use	 in	 this	
protocol.	 	 Cells	 which	 have	 been	 passed	 a	 large	 number	 of	 times	 may	 have	 developed	
chromosomal	abnormalities	and	should	not	be	used	in	the	culture.		
v. Proceed	to	step	2	when	you	have	plates	of	TSC	and	ESC	cells	(from	option	B)	that	are	both	
80%	confluent.	
	
	
B)	ESC	culture	
i. Cover	the	wells	of	a	12-well	tissue	culture	plate	with	0.01%	gelatin	(wt/vol)	solution	overnight.		
ii. Thaw	a	vial	of	frozen	ESCs	as	quickly	as	possible	and	re-suspend	in	the	medium	in	which	the	
cells	were	derived	(FC2iLIF	or	N2B27	2iLIF).		
?	TROUBLESHOOTING	
iii. Remove	the	excess	gelatin	from	one	well	of	the	12-well	plate	and	seed	the	ESCs.	Typically,	
~1.5	×	105	ESCs	can	be	plated	per	well	of	the	12-well	plate.			Incubate	the	ESCs	overnight	to	
attach,	then	replace	the	medium	with	fresh	FC2iLIF	or	N2B272iLIF.		
iv. Culture	cells	at	5%	CO2	and	37°C,	changing	the	medium	every	other	day,	and	inspecting	the	
cultures	each	day	to	ensure	cells	are	heathy.	Healthy	ESCs	should	form	domed,	bright	colonies	
with	clear	boundaries.		Passage	the	ESCs	every	two	days,	or	when	the	well	reaches	confluency.		
To	passage	cells:	incubate	with	0.05%	trypsin-EDTA	for	a	maximum	of	5	minutes;	neutralise	
with	an	equal	volume	of	FC	medium	;	gently	disaggregate	cells	with	a	pipette;	spin	down	cells	
(1000g	for	5	minutes);	resuspend	in	FC2iLIF	or	N2B272iLIF;	and	plate	on	a	fresh	gelatin	coated	
plate28		
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CRITICAL	STEP	ESCs	can	be	passaged	up	to	~20	times	for	use	in	this	protocol.		Cells	which	have	
been	passed	a	large	number	of	times	may	have	developed	chromosomal	abnormalities	and	
should	not	be	used	in	the	culture.		
vi. Proceed	to	step	2	when	you	have	plates	of	ESC	and	TSC	cells	(from	option	A)	that	are	both	
80%	confluent.	
	
3D	embedding	of	ESCs	and	TSCs	TIMING	~	1	hour	
CRITICAL	To	minimise	time	out-of-the-incubator,	it	is	recommended	to	process	ESCs	and	TSCs	in	
parallel	(steps	2-7).		This	can	be	done	by	a	single	researcher	however	if	this	is	not	possible,	then	it	is	
recommended	to	trypsinize	and	re-suspend	the	ESCs	first,	then	keep	them	in	PBS	under	the	tissue	
culture	hood	whilst	working	with	the	TSCs.	
CRITICAL	If	it	is	useful	to	have	all	the	cells	in	the	same	plane	(for	example	when	imaging	multiple	
structures)	a	‘3D	on	top’	approach	can	be	used,	as	described	in	Box	1.			
2) Wash	ESCs	from	step	1	with	Phosphate	Buffered	Saline	(PBS)	and	treat	with	0.05%	trypsin-
EDTA	for	3	–	4	minutes	at	37°C.	
3) Inactivate	the	trypsin	using	FC	medium	to	obtain	a	single-cell	suspension,	and	collect	in	a	15ml	
falcon	tube.		
CRITICAL	STEP:	ESCs	should	be	dissociated	to	single	cells	by	pipetting.	The	ESCs	can	be	left	in	
suspension	at	room	temperature	under	the	tissue	culture	hood	whilst	working	with	the	TSCs.	
4) Wash	TSCs	from	step	1	with	PBS	and	then	treat	with	0.05%	trypsin-EDTA	for	4	minutes	at	37°C.	
5) Inactivate	the	trypsin	using	TS	medium	to	obtain	small	clumps	of	TSCs	in	suspension.	Collect	
the	suspension	in	a	15ml	falcon	tube.	
CRITICAL	STEP:	TSCs	should	be	pipetted	gently	2-3	 times	using	a	wide	pipette	 tip	 just	as	a	
P1000	to	preserve	small	clumps.	
?	TROUBLESHOOTING	
6) If	two	centrifuges	are	available,	one	centrifuge	can	be	used	to	work	with	ESCs	while	another	
can	be	used	for	TSCs	in	parallel.	Centrifuge	ESCs	for	5	minutes	at	1000g	at	room	temperature.		
and	centrifuge	the	TSC	suspension	for	3	–	4	minutes	at	1000g	at	room	temperature.	
7) After	centrifugation	of	ESCs,	resuspend	the	cells	in	PBS	and	centrifuge	a	second	time	to	‘wash’	
the	PD0325901,	CHIR99021	and	LIF	from	the	ESCs.		
CRITICAL	STEP:	Washing	of	ESCs	is	important	to	remove	2iLIF.		
8) After	 centrifugation	 of	 TSCs,	 remove	 the	 supernatant,	 and	 resuspend	 the	 pellet	 gently	 in	
RPMI/FBS	media.		
CRITICAL	STEP	The	handling	of	TSCs	should	be	gentle	to	preserve	small	clumps	of	2	to	8	cells.	
The	 size	 and	 number	 of	 cells	 in	 TSC	 clumps	 can	 be	 checked	 under	 the	 tissue-culture	
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microscope	at	each	stage	of	the	procedure.	Over-washing	can	reduce	viability	of	TSCs,	so	avoid	
this.	
9) After	 the	 second	 centrifugation	 of	 ESCs	 is	 complete,	 resuspend	 once	 again	 in	 PBS	 and	
centrifuge	a	third	time.	TSCs	can	be	left	at	room	temperature	in	the	tissue	culture	hood	while	
ESCs	are	centrifuged	for	the	third	time.	
10) After	the	third	centrifugation	of	ESC,	remove	the	supernatant	and	resuspend	the	cell	pellet	in	
PBS	to	obtain	a	single	cell	suspension.		
11) Using	 a	 haemocytometer,	 count	 ~3-5,000	 ESCs	 and	 3-5,000	 TSC	 clumps	 and	mix	 in	 a	 1:1	
suspension	in	a	fresh	15ml	falcon	tube.		
12) Centrifuge	 the	 mix	 for	 3-4	 minutes	 at	 1000g	 at	 room	 temperature,	 then	 remove	 the	
supernatant	carefully	using	a	P200	pipette,	without	disturbing	the	cell	pellet.	
3D	embedding	of	ESC	and	TSC	TIMING	
13) Resuspend	the	pellet	in	liquid	Matrigel	(~100ul	for	all	8	wells	of	the	μ-plate	(Ibidi)).		
CRITICAL	STEP:	The	use	of	growth-factor	reduced	Matrigel	is	recommended.	This	should	be	
batch	tested	on	cells	before	generating	ETS	embryos.	
CRITICAL	 STEP:	 Thaw	Matrigel	 on	 ice.	 Matrigel	 must	 be	 kept	 on	 ice	 in	 order	 to	 prevent	
solidification	during	the	cell	preparation.		
CRITICAL	STEP:	Pipette	tips	for	resuspending	the	cells	should	also	be	kept	at	4	0C	in	order	to	
prevent	solidification	of	Matrigel.	
14) Plate	the	Matrigel-cell	suspension	in	small	(10-20µl)	drops	on	μ-plates	(Ibidi)	and	allow	the	
matrix	to	solidify	for	2	minutes	at	37°C.	Plate	one	drop	per	well	of	the	plate.	
Once	the	Matrigel	is	solidified,	fill	each	culture	well	with	ETS-embryo	medium	and	culture	in	
5%	CO2	at	37°C.	?	TROUBLESHOOTING	
Co-culture	of	ESCs	and	TSCs	to	generate	ETS	embryos	TIMING-	maximum	6	days	
15) Culture	cells	in	ETS-embryo	medium	for	up	to	six	days	after	plating.	Inspect	cultures	every	day	
to	 monitor	 ETS-embryo	 formation.	 Change	 the	 medium	 every	 48h	 or	 when	 cells	 deplete	
nutrients,	 as	 indicated	 by	 the	 phenol	 red	 present	 in	 the	medium.	When	medium	 requires	
changing,	 the	 medium	 will	 change	 colour	 from	 a	 red-pink	 colour	 to	 a	 ‘straw-like’	 colour.		
Proceed	to	next	step	at	appropriate	time	point	for	your	experiment	(4,	5	or	6	of	culture).	
?	TROUBLESHOOTING	
Immunofluorescence	analysis	of	ETS	embryos	TIMING-	2-3	days	
16) Remove	the	medium	from	ETS-embryo	cultures	and	rinse	with	PBS,	then	fix	for	15	minutes	at	
room	temperature	in	4%	ice-cold	paraformaldehyde	(PFA)	in	PBS	(vol/vol).	The	PFA	will	lead	
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to	the	collapse	of	the	Matrigel	droplets,	and	structures	will	stick	to	the	optical	plastic/	glass	of	
the	culture	dish.	?	TROUBLESHOOTING	
17)	 After	 fixation,	 rinse	 samples	 twice	 in	 PBS	 for	 5	minutes	 each,	 then	 permeabilise	 at	 room	
temperature	for	10	minutes	in	0.3%	Triton-X-100,	0.1%	glycin	in	PBS	(vol/vol).	
PAUSE	POINT:	Following	fixation	samples	can	be	processed	immediately	for	immunofluorescence	
staining	or	left	in	PBS	up	to	2	weeks	at	4°C.	
18)	Rinse	again	 in	PBS,	 then	perform	primary	antibody	 incubation	at	4°C	overnight	 in	blocking	
buffer.	 	Examples	of	primary	antibodies	we	have	used	successfully	and	recommended	dilutions	
are	given	in	the	materials.		
19)	The	following	day,	remove	the	primary	antibody	in	blocking	buffer	and	wash	samples	three	
times	for	5	minutes	each	in	PBS	at	room	temperature	to	remove	unbound	antibody.		
20)	Perform	secondary	antibody	 incubation	with	an	appropriate	antibody	 in	blocking	buffer	at	
room	temperature	for	2	hours.	
PAUSE	POINT:	Incubation	with	secondary	antibody	can	also	be	performed	at	4°C	overnight.		
21)	 After	 incubation,	 wash	 the	 samples	 three	 times	 in	 PBS	 for	 5	 minutes	 each	 at	 room	
temperature,	then	incubate	in	DAPI	plus	PBS	for	a	further	1	hour	at	room	temperature.		
22)	Remove	the	DAPI/PBS	solution,	add	PBS	into	plates	and	image	ETS-embryo	structures	in	situ	
in	the	optical	plates	using	a	confocal	microscope	(Leica	or	equivalent).		?	TROUBLESHOOTING	
BOX	4:	‘3D	on	top’	protocol	for	ETS-embryo	generation	
For	imaging	a	high	number	of	structures,	it	is	useful	to	have	all	the	cells	in	the	same	plane	.For	this	
purpose,	a	‘3D	on	top’	approach	(modified	from		Lee	et	al.,	40)	can	be	used.	This	method	is	amenable	
to	the	use	of	different	optical	plates	of	different	sizes,	depending	on	the	purpose	of	the	experiment.	
The	modifications	to	the	main	procedure	required	to	establish	the	‘3D	on	top’	approach	for	8-well	μ-
plates	(Ibidi)	is	described	below	and		coating,	seeding	and	media	volumes	for	plates	of	different	sizes	
is	given	in	Supplementary	Table	1.		
1) Thaw	Matrigel	on	ice	before	beginning	the	experiment.		
2) Cover	all	8-wells	of	μ-plates	(Ibidi)	evenly	with	35ul	of	liquid	Matrigel	to	cover	the	surface.		
3) Place	the	plate	in	the	incubator	at	37°C	for	two	minutes,	or	until	the	Matrigel	has	solidified.		
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4) Add	100ul	of	PBS	to	each	well	of	the	Matrigel-coated	plate	and	place	in	the	incubator	until	
ready	to	use.	This	step	prevents	the	Matrigel	from	drying	out.	
5) Trypsinize	 and	wash	 cells	 as	 described	 in	 steps	 2-11	 of	 the	main	 procedure	 to	 yield	 a	 1:1	
mixture	of	ESCs	and	TSC	clumps	in	PBS.		
6) Remove	the	PBS	from	each	well	of	the	plate	and	seed	the	1:1	mix	of	ESCs	and	TSCs	in	a	25ul	
volume	and	allow	them	to	attach	for	10-15	minutes	in	the	incubator.		
CRITICAL	STEP:	The	cells	must	be	allowed	to	attach	in	the	incubator	before	proceeding.	If	cells	
do	not	attach,	they	will	be	removed	during	later	steps	and	ETS	embryos	will	not	be	generated.		
7) Prepare	a	mixture	of	ETS	medium	and	10%	liquid	Matrigel	(vol/vol),	and	keep	this	on	ice	until	
ready	to	use.	
8) Once	the	cells	have	attached,	remove	the	extra	PBS	with	a	vacuum	pump	or	carefully	using	a	
pipette	and	fill	each	well	of	the	plate	with	a	mixture	of	ETS	medium	and	10%	(vol/vol)	Matrigel.	
9) Culture	cells	in	5%	CO2	at	37°C	for	up	to	six	days	after	plating.	Inspect	cultures	every	day	to	
monitor	ETS-embryo	formation.	
END	BOX	
?	TROUBLESHOOTING	
See	Table	1	for	troubleshooting	guidance.	
Table	1:		Troubleshooting	
Step	 Problem	
Possible	
Reason	
Possible	solution	
Step	
1Aiii,	
1Bii	
Low	rate	
and	density	
of	growth	of	
structure	in	
ECM	
Low	rate	of	cell	
survival/	
recovery	after	
thawing	
Keep	cells	in	adherent	culture	for	at	least	one	passage	after	
thawing	to	increase	the	number	of	cells	before	attempting	an	
ETS-embryo	experiment	
	
Step	
1Aiii,	
1Bii	
Formation	
of	
disorganised	
structures	
which	do	
Use	of	
differentiated	
ESCs	and	TSCs	
in	the	protocol	
Maintain	cells	in	conditions	to	preserve	stem	cell	character	
and	prevent	differentiation.	Inspect	plates	for	morphological	
evidence	of	differentiation	(altered	colony	morphology	in	ESC	
cultures	and	presence	of	trophoblast	giant	cells	in	TSC	
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not	
resemble	
the	egg	
cylinder	
cultures)	and	do	not	use	cells	in	the	protocol	that	are	
differentiated.	
Step	
5	
Low	rate	of	
TSC	survival	
in	ECM	
TSC	viability	
can	be	
compromised	
if	dissociated	
to	single	cells	
Preserve	small	clumps	by	dissociating	pellets	gently	after	
centrifugation.	If	TSCs	are	prone	to	dissociating	into	single	
cells,	suspend	cells	using	a	wide	P1000	filter	tip	to	avoid	
complete	dissociation	of	clumps.	
Step	
14	
Low	rate	of	
ETS	embryo	
generation	
and	survival	
If	ESCs	and	
TSCs	remain	
out	of	culture	
for	prolonged	
time	than	
recommended,	
ETS-embryo	
generation	can	
be	
compromised	
due	to	the	
decreased	
survival	of	the	
cells.	
It	is	recommended	to	work	with	ESCs	and	TSCs	in	parallel	to	
generate	the	mixed	cell	suspension	in	order	to	minimise	the	
time	that	cells	are	handled	in	suspension.	If	this	is	not	possible	
keeping	the	cells	in	buffered-based	media	can	be	used.	
	
Step	
15	
High	rate	of	
cell	death	
among	ESCs	
in	the	first	
48h	during	
ETS	embryo	
generation	
and	culture	
Medium	
change	is	too	
infrequent	
Change	the	medium	every	day	if	high	levels	of	cell	death	is	
observed	and	the	media	pH	(indicated	by	phenol	red)	changes	
rapidly.	
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Step	
16	
Matrigel	
drops	do	
not	collapse	
upon	
fixation	
PFA	is	too	
dilute	and	not	
kept	ice-cold.	
Or	very	few	
cells	have	
survived	in	the	
Matrigel.	
Ensure	the	PFA	is	kept	on	ice	throughout	the	procedure	and	
that	4%	PFA	in	PBS	is	used.	
Step	
22	
High	
background	
and	non-
specific	
fluorescence	
is	detected	
upon	
imaging	
Non-specific	
antibody	is	
retained	in	the	
samples	due	to	
insufficient	
washing	
Lengthen	the	time	of	washing	steps	to	10min	to	ensure	all	
unbound	primary	and	secondary	antibody	is	removed.	
	
TIMING		
• Step	1	Cell	culture	(A,B)	Culture	of	ESCs	and	TSCs	for	experiment	~	1	week	
• Steps	2-14	Embedding	of	ESCs	and	TSCs	in	ECM	for	co-culture	~	1	hour	
• Step	15	Culture,	monitoring	and	media	changes	~	6	days	
• Steps	16-22	Analysis	of	ETS-embryos	by	immunofluorescence	~	2-3	days	
BOX	1	Steps	1-8	‘3D	on	top’	plating	~	1	hour	
BOX	1	Step	9	Co-culture	to	generate	ETS-embryos	~	6	days	
	
ANTICIPATED	RESULTS	
ESCs	and	TSCs	 in	 close	proximity	 should	generate	 rosette-like	 structures	 that	 contact	each	
other	within	48h.	After	72h	compound	structures	with	a	 lumen	in	the	ESC	compartment	should	be	
present,	 and	 after	 96h,	 the	 two	 tissue	 compartments	 should	 share	 a	 common	 cavity	 (Fig.	 1).	 The	
efficiency	of	ETS-embryo	formation	is	variable,	with	an	average	of	22%	of	structures	per	well	forming	
embryo-like	structures17	within	4	days	of	culture	(400	structures	were	analysed	in	culture	to	calculate	
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this	value	for	efficiency,	with	88	structures	forming	compound	structures).	At	this	stage,	ETS-embryos	
vary	slightly	in	the	number	of	cells	which	make	up	the	ESC	and	TSC	compartments	respectively,	but	
are	 consistent	 in	 sharing	 a	 continuous	 cavity	 at	 the	 centre	 of	 the	 structure	 by	 96h.	 Compound	
structures	can	be	considered	as	representative	ETS	embryos	therefore	if	they	develop	this	continuous	
cavity	and	if	ESC	and	if	ESCs	and	TSC	compartments	occupy	approximately	50%	of	total	tissue	volume	
each17.		
It	is	important	that	ESCs	are	cultured	to	preserve	the	naïve	pluripotent	state	before	use	in	the	
protocol.	If	ESCs	are	allowed	to	differentiate	in	culture,	ETS-embryo	generation	can	be	compromised.	
Differentiated	ESCs	can	give	rise	to	ETS-embryos	with	disorganised	ESC	compartments,	which	fail	to	
organise	a	columnar	epithelium,	or	a	continuous	pro-amniotic	cavity.	Similar	structure	morphology	
can	be	seen	when	too	much	serum	is	used	in	the	ETS-embryo	medium.	If	differentiated	TSCs	are	used	
in	this	protocol,	compound	structures	fail	to	grow	in	culture.		
If	cell	viability	is	good,	100%	of	ETS-embryos	will	express	lineage	markers	determining	the	cell	
identity	 in	 discrete	 embryonic	 and	 extraembryonic	 compartments	 (Fig.	 2).	 However,	 mesodermal	
specification	among	ETS-embryos	is	variable.	We	found	that	66%	of	the	structures	in	culture	that	can	
be	considered	as	ETS-embryos	will	specify	some	cells	as	mesoderm	(by	the	detection	of	T/Brachury	
expression)	somewhere	 in	the	ESC	compartment	of	 the	structure.	43%	of	ETS	embryos	will	 specify	
mesoderm	which	 is	 ‘regionalised’	 in	that	 it	 is	 localised	to	one	side	of	the	 long	axis	of	the	structure	
within	 4-5	 days.	 34%	 of	 ETS-embryos	 fail	 to	 specify	 any	 T/Brachyury	 positive	 cells	 in	 the	 ESC	
compartment.	
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Figure	legends	
Figure	1:	Generation	of	polarised	embryo-like	structures	from	embryonic	and	extra-embryonic	stem	
cells	to	form	ETS-embryos.	Schematic	of	the	method	used	to	generate	ETS-embryos	from	ESCs	and	
TSCs.	 (a)	 When	 80%	 confluent,	 ESCs	 and	 TSCs	 are	 dissociated	 into	 single	 cells	 and	 small	 clumps	
respectively	(Steps	2-10).	Images	from	the	haemocytometer	square	(0.25	x	0.25	mm)	to	count	single	
ESCs	and	TSC	clumps	(Step	11)	Scale	bar=	50µm.	(b)	Mixing	and	resuspension	of	cells	in	liquid	Matrigel	
(Steps	12,	13)	 (c)	Plate	cell-Matrigel	 suspension	 in	small	drops,	allow	to	solidify	and	culture	 in	ETS	
medium	 (Step	 14)	 (d)&(e)	 The	 ‘3D	 on	 top’	 variation	 of	 culture	 (described	 in	 Box	 4.)	 (f)	 Low-
magnification	of	confocal	images	of	the	culture	plate	at	indicated	time	points	showing	the	co-culture	
of	CAG-GFP	labelled	ESCs	and	wild-type	TSCs	on	Matrigel.	Single	ESCs	and	TSC	clumps	(3h,	inset)	grow	
to	produce	single	spheroid	of	ESC	or	TSC	colonies	(24h,	inset)	which	later	come	together	(48-72h)	and	
finally	 merge	 to	 generate	 embryo-like	 structures,	 ETS-embryos	 (96h).	 Scale	 bar=	 50µm.	 (g)	 Time	
scheme	of	ETS-embryo	generation.	 (h)	High-magnification	of	confocal	 snapshots	of	an	ETS-embryo	
developing	over	96h	from	clumps	of	cells.	Within	12h,	the	single	ESC	divides	to	give	rise	to	a	doublet	
and	later	a	spheroid	of	polarised	cells,	which	later	merges	with	the	TSCs	to	generate	an	ETS-embryo.	
The	ESC	compartment	 is	 labelled	with	a	CAG-GFP	membrane	marker	to	demarcate	 it	 from	the	TSC	
compartment.	Yellow	dashed	lines	outline	the	cavity.	Scale	bar=	10µm.	
Figure	2:	Molecular	markers	ascertaining	to	the	lineage	identity	of	the	cell	types	in	the	embryonic	
and	extra-embryonic	compartments	of	polarised	embryo-like	structures,	ETS-embryos.	ETS-embryos	
cultured	for	110h	were	analysed	for	ExE	markers	(EOMES,	grey	(a);	TFAP2C,	grey	(b));	epiblast	markers	
(SOX2,	red	(a);	OTX2,	red	(b))	and	mesoderm	marker	(T/Brachyury,	green)	by	immunofluorescence.	
DAPI,	blue;	Scale	bar=	20µm.	
Supplementary	table	1:	Table	listing	the	approximate	volumes	of	medium	and	Matrigel	used	with	
this	method	for	different	sizes	and	types	of	optical	culture	dish.	
	
